Literature DB >> 9792398

Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997.

C D Holtzer, M A Jacobson, W K Hadley, L Huang, H D Stanley, R Montanti, M K Wong, J D Stansell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9792398

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  27 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

2.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

3.  Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Authors:  Elizabeth A Sugar; Douglas A Jabs; Alka Ahuja; Jennifer E Thorne; Ronald P Danis; Curtis L Meinert
Journal:  Am J Ophthalmol       Date:  2012-02-04       Impact factor: 5.258

Review 4.  HIV-1 drug resistance genotyping. A review of clinical and economic issues.

Authors:  C Chaix-Couturier; C Holtzer; K A Phillips; I Durand-Zaleski; J Stansell
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

5.  Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Authors:  Douglas A Jabs; Alka Ahuja; Mark Van Natta; Alice Lyon; Sunil Srivastava; Sapna Gangaputra
Journal:  Ophthalmology       Date:  2010-07-29       Impact factor: 12.079

6.  Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.

Authors:  Douglas A Jabs; Mark L Van Natta; Gary N Holland; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2016-10-27       Impact factor: 5.258

7.  Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.

Authors:  Douglas A Jabs; Alka Ahuja; Mark L Van Natta; Alice T Lyon; Steven Yeh; Ronald Danis
Journal:  Ophthalmology       Date:  2015-04-17       Impact factor: 12.079

8.  Incidence of Intermediate-stage Age-related Macular Degeneration in Patients With Acquired Immunodeficiency Syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Jeong Won Pak; Ronald P Danis; Peter W Hunt
Journal:  Am J Ophthalmol       Date:  2017-05-10       Impact factor: 5.258

9.  Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2015-03-11       Impact factor: 5.258

10.  Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Authors:  Sapna Gangaputra; Lea Drye; Vijay Vaidya; Jennifer E Thorne; Douglas A Jabs; Alice T Lyon
Journal:  Am J Ophthalmol       Date:  2012-10-12       Impact factor: 5.258
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.